Journal
JOURNAL OF CLINICAL MICROBIOLOGY
Volume 52, Issue 3, Pages 1016-1019Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.03176-13
Keywords
-
Categories
Funding
- Astellas
- Merck
Ask authors/readers for more resources
We report a patient with relapsed acute myelogenous leukemia after allogeneic stem cell transplantation who developed disseminated mucormycosis due to Rhizomucor pusillus/R. miehei involving lung, brain, and skin. After failing posaconazole and being intolerant to amphotericin, he was treated effectively with isavuconazole for over 6 months despite ongoing treatment for relapsed leukemia.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available